Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder caused by genetic and environmental factors that results in degeneration of the nigrostriatal dopaminergic pathway in the brain. We analyzed neural cells generated from induced pluripotent stem cells (iPSCs) derived from PD patients and presymptomatic individuals carrying mutations in the PINK1 (PTEN-induced putative kinase 1) and LRRK2 (leucine-rich repeat kinase 2) genes, and compared them to those of healthy control subjects. We measured several aspects of mitochondrial responses in the iPSC-derived neural cells including production of reactive oxygen species, mitochondrial respiration, proton leakage, and intraneuronal movement of mitochondria. Cellular vulnerability associated with mitochondrial dysfunction in iPSC-derived neural cells from familial PD patients and at-risk individuals could be rescued with coenzyme Q(10), rapamycin, or the LRRK2 kinase inhibitor GW5074. Analysis of mitochondrial responses in iPSC-derived neural cells from PD patients carrying different mutations provides insight into convergence of cellular disease mechanisms between different familial forms of PD and highlights the importance of oxidative stress and mitochondrial dysfunction in this neurodegenerative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Moreover, PD patient iPSC-derived dopaminergic neurons harboring LRRK2 and PINK1 mutations showed impaired axonal outgrowth and deficient autophagic vacuole clearance which cause abnormal α-syn accumulation [38].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [38]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The pharmacological capability of Coenzyme Q10, rapamycin, and LRRK2 kinase inhibitor GW5074 were found in iPSC-derived neural cells from PD patients with LRRK2 and PINK1 mutations [38].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005 · cited 2×
“Subjects 3 and 4 were 59-year-old Caucasian twins (sister and brother) from a family with PD (family D) (9, 60).”
BackgroundSelf-citationCloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405 · cited 1×
“Dominantly inherited mutations in LRRK2 are associated with familial PD (9, 10) that is clinically and pathologically similar, but not identical, to the more common late-onset idiopathic form of the disease (11–14).”
BackgroundThe substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756 · cited 1×
“Our data are consistent with the hypothesis of cell type–specific vulnerability developed for PD patients, where the midbrain DA neurons are more vulnerable than neighboring neuronal subtypes that also express genes associated with familial PD (1, 53, 54).”
ResultGenome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Self-citationPINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
Self-citationBender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · cited 1×
“For example, the agerelated accumulation of dysfunctional mitochondria (55, 56) can be mimicked using low doses of mitochondrial stressors, such as valinomycin or MPP, which create controlled, widespread mitochondrial damage within a cell population.”
BackgroundHealy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Self-citationSatake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Research works printed but not linked: 1
- 10.1093/hmg/ddi178 · DOI · Paper page
Cited by
Biological Functions of Autophagy Genes: A Disease Perspective
Levine, B., & Kroemer, G. (2019) · Cell · doi:10.1016/j.cell.2018.09.048 · Cited by 2,832
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,254
“It is also evidenced that neurons with mutations in protein LRRK2 are more vulnerable to mitochondrial toxins [119].”
BackgroundThe Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
“Further, iPSC cells from LRRK2 mutant human subjects exhibit increased vulnerability to MPP+ [325].”
BackgroundInduced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525
Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Sulaiman Rahman, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,149
Metadata
- Authors
- Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., Hargus, G., Deleidi, M., Lawson, T., Bogetofte, H., Perez-Torres, E., Clark, L., Moskowitz, C., Mazzulli, J., Chen, L., Volpicelli-Daley, L., Romero, N., Jiang, H., Uitti, R. J., Huang, Z., Opala, G., Scarffe, L. A., Dawson, V. L., Klein, C., Feng, J., Ross, O. A., Trojanowski, J. Q., Lee, V. M.-Y., Marder, K., Surmeier, D. J., Wszolek, Z. K., Przedborski, S., Krainc, D., Dawson, T. M., & Isacson, O.
- Affiliations
- Harvard University (US)
- Johns Hopkins University (US)
- Departments of Neurology, Psychiatry, and Pathology and Cell Biology, Sergievsky Center, Taub Institute and the Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
- Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
- Northwestern University (US)
- Columbia University Irving Medical Center (US)
- Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
- University at Buffalo, State University of New York (US)
- Mayo Clinic in Florida (US)
- University of Florida (US)
- Medical University of Silesia (PL)
- University of Lübeck (DE)
- University of Pennsylvania (US)
- Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
- Neuroregeneration Institute, McLean Hospital/Harvard Medical School, Belmont, MA 02478, USA.
- Corresponding author
- Cooper, Oliver
- Seo, Hyemyung
- Andrabi, Shaida
- Graziotto, John
- Sundberg, Maria
- McLean, Jesse R.
- Xie, Zhong
- Osborn, Teresia
- Hargus, Gunnar
- Deleidi, Michela
- Lawson, Tristan
- Bogetofte, Helle
- Perez-Torres, Eduardo
- Clark, Lorraine
- Moskowitz, Carol
- Mazzulli, Joseph
- Chen, Li
- Romero, Norma
- Jiang, Houbo
- Uitti, Ryan J.
- Scarffe, Leslie A.
- Dawson, Valina L.
- Feng, Jian
- Ross, Owen A.
- Trojanowski, John Q.
- Lee, Virginia M.-Y.
- Marder, Karen
- Surmeier, D. James
- Przedborski, Serge
- Krainc, Dimitri
- Dawson, Ted M.
- ORCID
- Cooper, Oliver
- Seo, Hyemyung
- Andrabi, Shaida
- Graziotto, John
- Sundberg, Maria
- Xie, Zhong
- Hargus, Gunnar
- Deleidi, Michela
- Bogetofte, Helle
- Clark, Lorraine
- Mazzulli, Joseph
- Chen, Li
- Jiang, Houbo
- Uitti, Ryan J.
- Scarffe, Leslie A.
- Dawson, Valina L.
- Klein, Christine
- Feng, Jian
- Ross, Owen A.
- Trojanowski, John Q.
- Lee, Virginia M.-Y.
- Marder, Karen
- Surmeier, D. James
- Przedborski, Serge
- Krainc, Dimitri
- Dawson, Ted M.
- Venue
- Science Translational Medicine
- Published
- 2012-07-04
- Volume
- 4
- Issue
- 141
- Pages
- 141ra90-141ra90
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC3462009
- OpenAlex
- W2102424187
- Cited by
- 508
- References
- 72
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 13 · 2023: 22 · 2022: 37 · 2021: 36 · 2020: 39 · 2019: 42 · 2018: 52 · 2017: 47 · 2016: 50 · 2015: 52 · 2014: 50 · 2013: 36 · 2012: 6
- FWCI
- 29.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Royal Society of Chemistry’s Journals, Books and Databases (The Royal Society of Chemistry) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000064, 5rc2ns070276-02)
- National Institute of Neurological Disorders and Stroke (NS 38377, RC2-NS070276, NS057567, R56NS036630, 1RC2-NS070276, R01NS036630, U24NS078338, R01NS057567, R01NS061856, P50NS038377, P50NS072187)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- Parkinson's disease, familial Parkinson's disease, iPSC-derived neural cells, mitochondrial dysfunction, PINK1 mutations, LRRK2 mutations, coenzyme Q10, rapamycin, GW5074, LRRK2 inhibitors, reactive oxygen species, mitochondrial respiration, proton leak, mitochondrial dynamics, oxidative stress, presymptomatic carriers, dopaminergic neurons
- MeSH terms
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Humans, Indoles, Mitochondria, Neurons, Parkinson Disease, Phenols, Ubiquinone, Protein Serine-Threonine Kinases, Sirolimus, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease. https://app.cochat.ai/papers/10.1126/scitranslmed.3003985
- The paper
- Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., Hargus, G., Deleidi, M., Lawson, T., Bogetofte, H., Perez-Torres, E., Clark, L., Moskowitz, C., Mazzulli, J., Chen, L., . . . Isacson, O. (2012). Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3003985
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.